Health Care Industry News
BioMimetic completes 100 day PMA meeting with FDA for Augment Bone Graft
News-Medical.Net | 14 minutes ago
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced it completed its 100 day Premarket Approval Application (PMA) meeting with the Food and Drug Administration (FDA) regarding the review of Augmentâ?¢ Bone Graft for the treatment of foot and ankle fusions in the U... (more)
Latest Health Care Industry NewsMore >
J&J launches 5-year aid program for women, children
Yahoo! | 1 hour 28 minutes ago
Wyeth paid writers to promote hormone therapy: study
Yahoo! | 1 hour 29 minutes ago
Readers ChoiceMore >
Roche works on a cost-cutting strategy
BIO SmartBrief | Sep 07, 2010
Bristol plans to acquire ZymoGenetics for $885 million
BIO SmartBrief | Sep 08, 2010
Sale of Genzyme is possible if the price is right, CEO says
BIO SmartBrief | Sep 02, 2010
Takeda buys North American marketing rights to Orexigen's Contrave
BIO SmartBrief | Sep 03, 2010
Silence Therapeutics is approached about a possible takeover
BIO SmartBrief | Sep 07, 2010
BIO News
More >
BIO Asia save-the-date reminder -- Jan. 24 and 25, 2011
BIO SmartBrief | Sep 08, 2010
2011 BIO International Convention Call for Session Proposals
BIO SmartBrief | Sep 07, 2010
BIOtech Now
BIO SmartBrief | Sep 03, 2010
Feeling the pinch in today's market hurts
BIO SmartBrief | Sep 02, 2010
Presentations from more than 130 companies at the BIO Investor Forum
BIO SmartBrief | Sep 01, 2010
Latest Health Care Industry Press ReleasesMore >
PAREXEL International to Present at Stifel Nicolaus Healthcare Conference
PRNewswire | 14 minutes ago
Clarient Presentation Time Change at the Baird 2010 Health Care Conference
PRNewswire | 14 minutes ago
Orasi Medical Partners to Improve Neurological Drug Development
MarketWire | 14 minutes ago
Affymetrix to Webcast Presentations at September Financial Conferences
Business Wire | 14 minutes ago
Key Alert: TapImmune Announcements Are a Critical Step in the Company's Development
MarketWire | 1 hour 44 minutes ago
Santarus to Present at September Investment Conferences
Business Wire | 2 hours 14 minutes ago
Sign up for BIO SmartBrief
Latest Blog Postsview more
Use of medication for insomnia or anxiety increases mortality risk by 36 percent
Science Blog
The public looks at synthetic biology cautiously
Science Blog
Using chest compressions first just as successful as immediate defibrillation after cardiac arrest
Science Blog
Abnormal body weight related to increased mortality in colon cancer patients
Science Blog